Biomarker analysis of on-treatment and at progression biopsies from BRIM7 - a phase 1B trial of combined vemurafenib and cobimetinib treatment in BRAF V600 mutated melanoma
Crossref DOI link: https://doi.org/10.1186/1479-5876-12-S1-O12
Published Online: 2014-05-06
Published Print: 2014-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yan, Yibing
McArthur, Grant
Hamid, Omid
Puzanov, Igor
Gonzalez, Rene
Gajewski, Thomas
Wang, Yulei
Wongchenko, Matthew
Choong, Nicholas
Ribas, Antoni
Article History
First Online: 6 May 2014